Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.


Journal

Acta neuropathologica
ISSN: 1432-0533
Titre abrégé: Acta Neuropathol
Pays: Germany
ID NLM: 0412041

Informations de publication

Date de publication:
12 2019
Historique:
received: 08 01 2019
accepted: 31 07 2019
revised: 26 07 2019
pubmed: 16 8 2019
medline: 25 9 2020
entrez: 16 8 2019
Statut: ppublish

Résumé

Extracellular deposition of amyloid β-protein (Aβ) in amyloid plaques and intracellular accumulation of abnormally phosphorylated τ-protein (p-τ) in neurofibrillary tangles (NFTs) represent pathological hallmark lesions of Alzheimer's disease (AD). Both lesions develop in parallel in the human brain throughout the preclinical and clinical course of AD. Nevertheless, it is not yet clear whether there is a direct link between Aβ and τ pathology or whether other proteins are involved in this process. To address this question, we crossed amyloid precursor protein (APP) transgenic mice overexpressing human APP with the Swedish mutation (670/671 KM → NL) (APP23), human wild-type APP (APP51/16), or a proenkephalin signal peptide linked to human Aβ

Identifiants

pubmed: 31414210
doi: 10.1007/s00401-019-02053-5
pii: 10.1007/s00401-019-02053-5
doi:

Substances chimiques

Amyloid beta-Peptides 0
Amyloid beta-Protein Precursor 0
Prion Proteins 0
tau Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

913-941

Subventions

Organisme : Fonds Wetenschappelijk Onderzoek
ID : G0F8516N
Pays : International
Organisme : Alzheimer Forschung Initiative
ID : #10810
Pays : International
Organisme : Vlaamse Overheid
ID : IWT 135043
Pays : International

Auteurs

Luis Aragão Gomes (LA)

Laboratory for Neuropathology, Department of Imaging and Pathology, KU-Leuven, Leuven, Belgium.
Leuven Brain Institute, KU-Leuven, Leuven, Belgium.

Silvia Andrea Hipp (SA)

Laboratory for Neuropathology, Institute of Pathology, University of Ulm, Ulm, Germany.
Anasthesiology and Intensive Medicine, University Hospital of Tübingen, Tübingen, Germany.

Ajeet Rijal Upadhaya (A)

Laboratory for Neuropathology, Institute of Pathology, University of Ulm, Ulm, Germany.

Karthikeyan Balakrishnan (K)

Laboratory for Neuropathology, Institute of Pathology, University of Ulm, Ulm, Germany.
Department of Gene Therapy, University of Ulm, Ulm, Germany.

Simona Ospitalieri (S)

Laboratory for Neuropathology, Department of Imaging and Pathology, KU-Leuven, Leuven, Belgium.
Leuven Brain Institute, KU-Leuven, Leuven, Belgium.

Marta J Koper (MJ)

Laboratory for Neuropathology, Department of Imaging and Pathology, KU-Leuven, Leuven, Belgium.
Leuven Brain Institute, KU-Leuven, Leuven, Belgium.
Laboratory for the Research of Neurodegenerative Diseases, Department of Neurosciences, KU Leuven (University of Leuven), Leuven, Belgium.
VIB, Center for Brain and Disease Research, Leuven, Belgium.

Pablo Largo-Barrientos (P)

VIB, Center for Brain and Disease Research, Leuven, Belgium.
Department of Neurosciences, KU-Leuven, Leuven, Belgium.

Valerie Uytterhoeven (V)

VIB, Center for Brain and Disease Research, Leuven, Belgium.
Department of Neurosciences, KU-Leuven, Leuven, Belgium.

Julia Reichwald (J)

Novartis Institutes for Biomedical Sciences, Basel, Switzerland.

Sabine Rabe (S)

Novartis Institutes for Biomedical Sciences, Basel, Switzerland.

Rik Vandenberghe (R)

Leuven Brain Institute, KU-Leuven, Leuven, Belgium.
Experimental Neurology Group, Department of Neurosciences, KU Leuven, Leuven, Belgium.
Department of Neurology, UZ-Leuven, Leuven, Belgium.

Christine A F von Arnim (CAF)

Department of Neurology, University of Ulm, Ulm, Germany.
Clinic for Neurogeriatrics and Neurological Rehabilitation, University- und Rehabilitation Hospital Ulm (RKU), Ulm, Germany.

Thomas Tousseyn (T)

Department of Pathology, UZ Leuven, Leuven, Belgium.

Regina Feederle (R)

Institute for Diabetes and Obesity, Monoclonal Antibody Research Group, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), 81377, Munich, Germany.

Camilla Giudici (C)

German Center for Neurodegenerative Diseases (DZNE) Munich, 81377, Munich, Germany.

Michael Willem (M)

Chair of Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-University Munich, 81377, Munich, Germany.

Matthias Staufenbiel (M)

Novartis Institutes for Biomedical Sciences, Basel, Switzerland.

Dietmar Rudolf Thal (DR)

Laboratory for Neuropathology, Department of Imaging and Pathology, KU-Leuven, Leuven, Belgium. Dietmar.Thal@kuleuven.be.
Leuven Brain Institute, KU-Leuven, Leuven, Belgium. Dietmar.Thal@kuleuven.be.
Laboratory for Neuropathology, Institute of Pathology, University of Ulm, Ulm, Germany. Dietmar.Thal@kuleuven.be.
Department of Pathology, UZ Leuven, Leuven, Belgium. Dietmar.Thal@kuleuven.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH